School of Medicine
Showing 31-40 of 343 Results
-
Nathaniel Aidan Blecher
Clinical Assistant Professor, Ophthalmology
BioDr. Nathaniel Blecher is a board-certified, fellowship-trained ophthalmologist who specializes in glaucoma care at Stanford Health Care. He is also a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
His clinical interests include innovative surgical treatments for glaucoma—including minimally invasive glaucoma surgery (MIGS)—as well as the connection between lifestyle and ocular health. Dr. Blecher provides comprehensive care for the full spectrum of glaucoma, both early-stage and particularly advanced disease.
His individualized approach includes laser therapy, medical management, MIGS procedures, and more complex interventions such as tube shunt placement and trabeculectomy. He also treats coexisting conditions like cataracts, ensuring patients receive coordinated, whole-eye care.
Dr. Blecher’s research interests include treatments for pseudophakic angle closure, which is a rare situation when high pressure inside the eye suddenly develops despite cataract surgery. He has also studied the finer details of correctly detecting glaucoma progression based on optical coherence tomography (OCT) analysis, considering the changes that can be seen from comorbid conditions such as hypertension and diabetes.
Dr. Blecher’s research has been published in leading peer-reviewed journals, including Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery, and Ophthalmology Case Reports. He has presented internationally on topics such as MIGS and complex glaucoma management.
He is a member of the American Academy of Ophthalmology and the American Glaucoma Society. -
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations.
